Europe Gastrointestinal Drugs Market : Table of Contents

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. Europe Gastrointestinal Drugs Market – Key Market Dynamics

4.1 Market Drivers

4.1.1 Rising Cases of Gastrointestinal Diseases

4.1.2 Increasing Development of Biologics

4.2 Market Restraints

4.2.1 High Cost of Biologics

4.2.2 Average Cost of Biologic Drugs for Severe Ulcerative Colitis or Crohn's Disease

4.3 Market Opportunities

4.3.1 Strategic Initiatives by Companies

4.4 Future Trends

4.4.1 Increasing Research Investment for Novel Drug Development and Artificial Intelligence-Based Techniques

4.5 Impact of Drivers and Restraints:

5. Gastrointestinal Drugs Market – Europe Analysis

5.1 Europe Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

6. Europe Gastrointestinal Drugs Market Analysis – by Drug Class

6.1 Biologics

6.1.1 Overview

6.1.2 Biologics: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.2 Antidiarrheal and Laxatives

6.2.1 Overview

6.2.2 Antidiarrheal and Laxatives: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.3 Acid Neutralizers

6.3.1 Overview

6.3.2 Acid Neutralizers: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.4 Anti-inflammatory Drugs

6.4.1 Overview

6.4.2 Anti-inflammatory Drugs: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.5 Antiemetic and Antinauseants

6.5.1 Overview

6.5.2 Antiemetic and Antinauseants: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.6 Others

6.6.1 Overview

6.6.2 Others: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7. Europe Gastrointestinal Drugs Market Analysis – by Application

7.1 Irritable Bowel Syndrome

7.1.1 Overview

7.1.2 Irritable Bowel Syndrome: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Inflammatory Ulcerative Colitis

7.2.1 Overview

7.2.2 Inflammatory Ulcerative Colitis: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Crohn's Disease

7.3.1 Overview

7.3.2 Crohn's Disease: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Gastroenteritis

7.4.1 Overview

7.4.2 Gastroenteritis: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Celiac Disease

7.5.1 Overview

7.5.2 Celiac Disease: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Gastrointestinal Drugs Market Analysis – by Route Of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Parenteral

8.2.1 Overview

8.2.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9. Europe Gastrointestinal Drugs Market Analysis – by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview

9.1.2 Hospital Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview

9.2.2 Retail Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Online Pharmacies

9.3.1 Overview

9.3.2 Online Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10. Europe Gastrointestinal Drugs Market – Country Analysis

10.1 Europe

10.1.1 Europe Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country

10.1.1.1 Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.1.2 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.1.3 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.1.4 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.2 United Kingdom: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 United Kingdom: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.2.2 United Kingdom: Europe Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.2.3 United Kingdom: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.2.4 United Kingdom: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.3 France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 France: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.3.2 France: Europe Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.3.3 France: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.3.4 France: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.4 Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.4.1 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.4.2 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.4.3 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.4.4 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.5 Spain: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.5.1 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.5.2 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.5.3 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.5.4 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.6 Rest of Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.6.1 Rest of Europe Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.6.2 Rest of Europe Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.6.3 Rest of Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.6.4 Rest of Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Gastrointestinal Drugs Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Sanofi SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 GSK Plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Johnson & Johnson

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bausch Health Companies Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 AstraZeneca Plc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Takeda Pharmaceutical Co Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 AbbVie Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Bayer AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Pfizer Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Gastrointestinal Drugs Market Segmentation

Table 2. Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 3. Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 4. Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 5. Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 6. United Kingdom: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 7. United Kingdom: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 8. United Kingdom: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 9. United Kingdom: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 10. France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 11. France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 12. France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 13. France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 14. Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 15. Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 16. Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 17. Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 18. Spain: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 19. Spain: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 20. Spain: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 21. Spain: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 22. Rest of Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 23. Rest of Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 24. Rest of Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 25. Rest of Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 26. Recent Organic Growth Strategies in Gastrointestinal Drugs Market

Table 27. Recent Inorganic Growth Strategies in the Gastrointestinal Drugs Market

Table 28. Glossary of Terms, Gastrointestinal Drugs Market

List of Figures

Figure 1. Europe Gastrointestinal Drugs Market Segmentation, by Country

Figure 2. Europe Gastrointestinal Drugs Market – Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

Figure 5. Europe Gastrointestinal Drugs Market Share (%) – by Drug Class (2023 and 2031)

Figure 6. Biologics: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. Antidiarrheal and Laxatives: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Acid Neutralizers: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. Anti-inflammatory Drugs: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Antiemetic and Antinauseants: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Others: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Europe Gastrointestinal Drugs Market Share (%) – by Application (2023 and 2031)

Figure 13. Irritable Bowel Syndrome: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Inflammatory Ulcerative Colitis: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Crohn's Disease: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Gastroenteritis: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Celiac Disease: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18. Others: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19. Europe Gastrointestinal Drugs Market Share (%) – by Route of Administration (2023 and 2031)

Figure 20. Oral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 21. Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22. Europe Gastrointestinal Drugs Market Share (%) – by Distribution Channel (2023 and 2031)

Figure 23. Hospital Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 24. Retail Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 25. Online Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26. Europe Gastrointestinal Drugs Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)

Figure 27. Europe Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 28. Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 29. United Kingdom: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 30. France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 31. Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 32. Spain: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 33. Rest of Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 34. Growth Strategies in Gastrointestinal Drugs Market